Drug Trial Radar · NCT04581629
Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1
Last checked: Nov 20, 2026Latest source record: Nov 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
Sep 20, 2020
Primary completion
Sep 7, 2023
Study completion Sep 7, 2023
Sponsor
- Lead sponsor
- Calcilytix Therapeutics, Inc., a BridgeBio companyIndustry
- Sponsor type
- Industry
- First posted
- Oct 9, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to evaluate the safety, tolerability and effectiveness of encaleret in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).
Conditions
- Autosomal Dominant Hypocalcemia (ADH)
- Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Interventions
EncaleretDrug
Tablets administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Periods 1, 2 and 3: Number of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: Day 1 up to 16 months
- Period 3: Change From Baseline in Albumin-Corrected Blood Calcium Concentrations (cCa)Time frame: Baseline, Week 24
- Period 3: Rate of Urinary Calcium ExcretionTime frame: Week 24
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Institutes of Health (NIH) Clinical Center
Bethesda, Maryland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.